Clinical Trial Update: Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml. [Phase 4]

View source ↗

Summary

A phase 4 clinical trial compares Taurolock Hep 100 with heparin 100 IE/mL as catheter lock solutions to prevent catheter-related bloodstream infections; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Drugs mentioned

• Heparin 100 IE/mL (heparin)
• Taurolock Hep 100 (taurolidine/heparin)

Snippet

Sponsor: Palle Bekker Jeppesen | Conditions: Catheter-related Bloodstream Infection (CRBSI) Nos | Phase 4 | Status: UNKNOWN